Yes, Abbvie paid the $21billion knowing that Jensen would continue getting their 50% profit share.
With that sharing in place, the drug has added some $30billion cummulatively to AbbVie's revenue, so they have some very well.
The revenues are going down due to increasing competition, but they still get over 4billion a year from that drug alone.
Noting too that they acquired the company itself with its asset (not just the drug asset)! Perhaps there is more to come?
- Forums
- ASX - By Stock
- RAC
- CPACS: Research, Results, Market Comparisons, and Valuations
CPACS: Research, Results, Market Comparisons, and Valuations, page-237
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.56 |
Change
-0.025(1.58%) |
Mkt cap ! $269.2M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.56 | $167.6K | 105.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1209 | 1.555 |
4 | 54981 | 1.550 |
1 | 639 | 1.530 |
1 | 700 | 1.520 |
1 | 639 | 1.515 |
Price($) | Vol. | No. |
---|---|---|
1.595 | 8522 | 2 |
1.600 | 20000 | 1 |
1.620 | 2626 | 2 |
1.635 | 626 | 1 |
1.685 | 5000 | 1 |
Last trade - 15.59pm 11/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |